Patient-reported urinary incontinence after radiotherapy for prostate cancer: Quantifying the dose-effect.

Published on Oct 1, 2017in Radiotherapy and Oncology4.856
· DOI :10.1016/J.RADONC.2017.07.029
Cesare Cozzarini43
Estimated H-index: 43
,
Tiziana Rancati27
Estimated H-index: 27
+ 11 AuthorsClaudio Fiorino54
Estimated H-index: 54
Sources
Abstract
Abstract Background and purpose Urinary incontinence following radiotherapy (RT) for prostate cancer (PCa) has a relevant impact on patient’s quality of life. The aim of the study was to assess the unknown dose–effect relationship for late patient-reported urinary incontinence (LPRUI). Methods and materials Patients were enrolled within the multi-centric study DUE01. Clinical and dosimetry data including the prescribed 2 Gy equivalent dose (EQD2) were prospectively collected. LPRUI was evaluated through the ICIQ-SF questionnaire filled in by the patients at RT start/end and therefore every 6 months. Patients were treated with conventional (74–80 Gy, 1.8–2 Gy/fr) or moderately hypo-fractionated RT (65–75.2 Gy, 2.2–2.7 Gy/fr) in 5 fractions/week with intensity-modulated radiotherapy. Six different end-points of 3-year LPRUI, including or not patient’s perception (respectively, subjective and objective end-points), were considered. Multivariable logistic models were developed for each end-point. Results Data of 298 patients were analyzed. The incidence of the most severe end-point (ICIQ-SF > 12) was 5.1%. EQD2 calculated with alpha–beta = 0.8 Gy showed the best performance in fitting data: the risk of LPRUI markedly increased for EQD2 > 80 Gy. Previous abdominal/pelvic surgery and previous TURP were the clinical factors more significantly predictive of LPRUI. Models showed excellent performances in terms of goodness-of-fit and calibration, confirmed by bootstrap-based internal validation. When included in the analyses, baseline symptoms were a major predictor for 5 out of six end-points. Conclusions LPRUI after RT for PCa dramatically depends on EQD2 and few clinical factors. Results are consistent with a larger than expected impact of moderate hypo-fractionation on the risk of LPRUI. As expected, baseline symptoms, as captured by ICIQ-SF, are associated to an increased risk of LPRUI.
📖 Papers frequently viewed together
20 Authors (Federica Palorini, ..., C. Fiorino)
References30
Newest
#1I. ImprotaH-Index: 5
#2Federica PaloriniH-Index: 11
Last. C. FiorinoH-Index: 7
view all 13 authors...
Abstract Purpose To assess bladder spatial-dose parameters predicting acute urinary toxicity after radiotherapy for prostate cancer (PCa) through a pixel-wise method for analysis of bladder dose-surface maps (DSMs). Materials & methods The final cohort of a multi-institutional study, consisting of 539 patients with PCa treated with conventionally (CONV:1.8–2 Gy/fr) or moderately hypo-fractionated radiotherapy (HYPO:2.2–2.7 Gy/fr) was considered. Urinary toxicity was evaluated through the Interna...
25 CitationsSource
#1Luca Incrocci (EUR: Erasmus University Rotterdam)H-Index: 38
#2Ruud C. Wortel (EUR: Erasmus University Rotterdam)H-Index: 8
Last. Floris J. Pos (NKI-AVL: Netherlands Cancer Institute)H-Index: 27
view all 11 authors...
Summary Background Studies have reported a low α/β ratio for prostate cancer, suggesting that hypofractionation could enhance the biological tumour dose without increasing genitourinary and gastrointestinal toxicity. In the multicentre phase 3, HYpofractionated irradiation for PROstate cancer (HYPRO) trial, hypofractionated radiotherapy was compared with conventionally fractionated radiotherapy for treatment of prostate cancer. We have previously reported acute and late incidence of genitourinar...
238 CitationsSource
#1Valeria LandoniH-Index: 20
#2Claudio FiorinoH-Index: 54
Last. Tiziana RancatiH-Index: 27
view all 6 authors...
Abstract This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009). The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as ra...
54 CitationsSource
#1Federica PaloriniH-Index: 11
#2Tiziana RancatiH-Index: 27
Last. C. FiorinoH-Index: 7
view all 20 authors...
Abstract Purpose/objective Prospectively assessing clinical/dosimetry factors affecting the acute worsening of urinary functionality after radiotherapy for prostate cancer. Material/methods DUE01 population was considered, including patients treated with conventional or moderate hypo-fractionation (2.2–2.7Gy/fr). Relevant clinical factors were collected, urinary symptoms were self-reported through the International Prostate Symptom Score (IPSS) before and at the end of radiotherapy; while absolu...
16 CitationsSource
Purpose To assess the macroscopic hematuria rates within a single-institution randomized phase 3 trial comparing dose-escalated, conventionally fractionated radiation therapy (CFRT) and moderately hypofractionated radiation therapy (MHRT) for localized prostate cancer. Methods and Materials Patients with intermediate- to high-risk localized prostate cancer were treated with conformal RT and short-course androgen deprivation. Both the prostate and the entire seminal vesicles were treated to 80 Gy...
11 CitationsSource
#1Talha Shaikh (Fox Chase Cancer Center)H-Index: 13
#2Tianyu Li (Fox Chase Cancer Center)H-Index: 33
Last. Eric M. Horwitz (Fox Chase Cancer Center)H-Index: 72
view all 14 authors...
Purpose To assess the long-term quality of life (QoL) outcomes from a phase 3 trial comparing 2 modes of intensity modulated radiation therapy (IMRT): conventional IMRT (CIMRT) versus hypofractionated IMRT (HIMRT) in patients with localized prostate cancer. Methods and Materials Between 2002 and 2006, 303 men with low-risk to high-risk prostate cancer were randomized to 76 Gy in 38 fractions (CIMRT) versus 70.2 Gy in 26 fractions (HIMRT). QoL was compared by use of the Expanded Prostate Cancer I...
32 CitationsSource
#1Cesare CozzariniH-Index: 43
#2Tiziana RancatiH-Index: 27
Last. Claudio FiorinoH-Index: 54
view all 14 authors...
Abstract Purpose A prospective trial started in 2010, aiming at developing models for urinary toxicity and erectile dysfunction after radiotherapy for prostate cancer. This analysis is finalised at highlighting correlations between clinical/dosimetric factors and acute urinary specific symptoms, as measured by single questions of the International Prostate Symptom Score (IPSS). Materials/methods IPSS was prospectively collected before and at the end of radiotherapy; absolute weekly bladder dose–...
19 CitationsSource
#1Noorazrul Azmie Yahya (UWA: University of Western Australia)H-Index: 5
#1Noorazrul Azmie Yahya (UWA: University of Western Australia)H-Index: 7
Last. James W. Denham (University of Newcastle)H-Index: 56
view all 7 authors...
Abstract Purpose/objective To identify dosimetry, clinical factors and medication intake impacting urinary symptoms after prostate radiotherapy. Material and methods Data describing clinical factors and bladder dosimetry (reduced with principal component (PC) analysis) for 754 patients treated with external beam radiotherapy accrued by TROG 03.04 RADAR prostate radiotherapy trial were available for analysis. Urinary symptoms (frequency, incontinence, dysuria and haematuria) were prospectively as...
24 CitationsSource
#1Cesare CozzariniH-Index: 43
#2Claudio FiorinoH-Index: 54
Last. Nadia Di MuzioH-Index: 31
view all 13 authors...
Abstract Background Dose escalation and hypofractionation may have a role in postprostatectomy radiotherapy (RT), but at the risk of increasing urinary toxicity. Objective To address predictors of severe (Grade ≥3) late urinary toxicities (LGUTOX3) after postoperative irradiation. Design, setting, and participants A single-institution cohort of 1176 patients treated between 1993 and 2010 with adjuvant or salvage RT was analyzed. A total of 929 patients underwent conventionally fractionated (CF) ...
65 CitationsSource
Purpose To fit urinary toxicity data of patients treated with postprostatectomy radiation therapy with the linear quadratic (LQ) model with/without introducing a time factor. Methods and Materials Between 1993 and 2010, 1176 patients were treated with conventional fractionation (1.8 Gy per fraction, median 70.2 Gy, n=929) or hypofractionation (2.35-2.90 Gy per fraction, n=247). Data referred to 2004-2010 (when all schemes were in use, n=563; conventional fractionation: 316; hypofractionation: 24...
19 CitationsSource
Cited By13
Newest
#1Fernando Munoz (AUSL: Academy for Urban School Leadership)H-Index: 11
#2Giuseppe SanguinetiH-Index: 37
Last. A. FaiellaH-Index: 5
view all 19 authors...
Background: Baseline urinary incontinence (UI) strongly modulates UI recovery after adjuvant/salvage radiotherapy (ART/SRT), inducing clinicians to postpone it “as much as possible”, maximizing UI recovery but possibly reducing efficacy. This series aims to analyze the trend of UI recovery and its predictors at radiotherapy start. Methods: A population of 408 patients treated with ART/SRT enrolled in a cohort study (ClinicalTrials.gov #NCT02803086) aimed at developing predictive models of radiat...
Source
#1Irmina Nahon (UC: University of Canberra)H-Index: 4
Last. Irmina Nahon (UC: University of Canberra)H-Index: 2
view all 1 authors...
Source
#1Benoit Clerc-Renaud (CSU: Colorado State University)H-Index: 1
#2Tracy L. Gieger (NCSU: North Carolina State University)H-Index: 12
Last. Michael W. Nolan (NCSU: North Carolina State University)H-Index: 10
view all 4 authors...
BACKGROUND Locoregional tumor control and prolonged survival for dogs with genitourinary carcinoma (CGUC) reportedly are achievable using treatment with radiotherapy (RT) with or without adjunctive chemotherapy and nonsteroidal anti-inflammatory drugs (NSAIDs). OBJECTIVES To characterize event-free and overall survival after treatment of CGUC using NSAIDs, mitoxantrone (MTX), and a standardized RT protocol (57 Gy in 20 fractions). ANIMALS Fifty-one client-owned dogs treated between 2008 and 2017...
Source
#1Arjun Nathan (University of Cambridge)
#1A. Nathan (University of Cambridge)H-Index: 1
Last. Benjamin W. LambH-Index: 21
view all 10 authors...
To assess whether the timing of post-operative Phosphodiesterase Inhibitor (PDE5i) therapy after Robot-Assisted Radical Prostatectomy (RARP) is associated with a change in early erectile function (EF) outcomes, continence or safety outcomes. Data were prospectively collected from a single surgeon in one tertiary centre. 158 patients were treated with PDE5i therapy post RARP over a 2-year period. PDE5i therapy was started: immediately (day 1-2) post-op in 29%, early (day 3-14) post-op in 37% and ...
1 CitationsSource
#1Ahmed ElshafeiH-Index: 14
#2Molly E. DeWitt-Foy (Cleveland Clinic)H-Index: 3
Last. Thomas J. Polascik (Duke University)H-Index: 69
view all 11 authors...
BACKGROUND To assess whether prior interventional treatment for benign prostatic hyperplasia (BPH) influences oncologic or functional outcomes following primary whole-gland prostate cryoablation. METHODS Among 3831 men with prostate cancer who underwent primary whole-gland prostate cryoablation, we identified 160 with a history of prior BPH interventional therapy including transurethral needle ablation (n = 6), transurethral microwave thermotherapy (n = 9), or transurethral resection of the pros...
Source
#1Andrea Bresolin (UniSR: Vita-Salute San Raffaele University)H-Index: 1
Last. Cesare Cozzarini (UniSR: Vita-Salute San Raffaele University)H-Index: 43
view all 20 authors...
Objective. To investigate predictors of patient-reported urinary incontinence (PRUI) in the first 2 years after post-prostatectomy radiotherapy (PORT) with particular emphasis on possible dose-effect relationships. Patients and Methods. Two-hundred-thirteen patients, whose clinical and dosimetric data were prospectively collected within a registered multi-institutional cohort study, underwent PORT with adjuvant (n=106) or salvage (n=107) intent with conventional (n=123, prescribed dose to the pr...
Source
#1Eugenia Mylona (French Institute of Health and Medical Research)H-Index: 4
#2Alessandro Cicchetti (UNIPV: University of Pavia)H-Index: 7
Last. Renaud de Crevoisier (French Institute of Health and Medical Research)H-Index: 28
view all 11 authors...
Abstract Purpose To perform bladder dose-surface map (DSM) analysis for (1) identifying symptom-related sub-surfaces (Ssurf) and evaluating their prediction capability of urinary toxicity, (2) comparing DSM with dose-volume map (DVM) (method effect), and (3) assessing the reproducibility of DSM (cohort effect). Methods and materials Urinary toxicities were prospectively analyzed for 254 prostate cancer patients treated with IMRT/IGRT at 78/80 Gy. DSMs were generated by unfolding bladder surfaces...
7 CitationsSource
#1Eva Onjukka (Karolinska University Hospital)H-Index: 4
#2Claudio FiorinoH-Index: 54
Last. Tiziana RancatiH-Index: 27
view all 11 authors...
AbstractPurpose: The aim of this work was to determine how the spatial pattern of dose in the ano-rectal wall is related to late gastro-intestinal toxicity for prostate cancer patients treated with...
10 CitationsSource
#1Catharine H. Clark (National Physical Laboratory)H-Index: 26
#2Giovanna Gagliardi (KI: Karolinska Institutet)H-Index: 26
Last. Ludvig Paul Muren (Aarhus University Hospital)H-Index: 31
view all 7 authors...
4 CitationsSource
#1Giuseppe Palma (National Research Council)H-Index: 14
#2Serena Monti (National Research Council)H-Index: 14
Last. Laura Cella (National Research Council)H-Index: 25
view all 5 authors...
Abstract Mathematical models of normal tissue complication probability (NTCP) able to robustly predict radiation-induced morbidities (RIM) play an essential role in the identification of a personalized optimal plan, and represent the key to maximizing the benefits of technological advances in radiation therapy (RT). Most modern RT techniques pose, however, new challenges in estimating the risk of RIM. The aim of this report is to schematically review NTCP models in the framework of advanced radi...
18 CitationsSource